⌘K

Login Start Free

Home/Filings/4/0001493152-19-004303

4//SEC Filing

Yeaton Howard 4

Accession 0001493152-19-004303

CIK 0001321834other

View on SEC.gov Company Profile

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 7:54 PM ET

Size

4.4 KB

Accession

0001493152-19-004303

Insider Transaction Report

Form 4

Period: 2019-03-29

Akers Biosciences, Inc.AKER

CEO, CFO

Transactions

Award
Common Stock
2019-03-29$0.97/sh+15,000$14,550→ 22,500 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Akers Biosciences, Inc.

CIK 0001321834

Entity typeother

Related Parties

1

filerCIK 0001341910

Filing Metadata

Form type: 4
Filed: Mar 28, 8:00 PM ET
Accepted: Mar 29, 7:54 PM ET
Size: 4.4 KB

View on SEC.gov